Belships ASA
10.3.2021 23:20:00 CET | Globenewswire | Press release
Reference is made to the announcement by Belships ASA (the "Company") on 9 March 2021 regarding the successfully completed private placement.
Please find information regarding the subscription that is regarded as PDMR trades under the Market Abuse Regulation (EU) No 596/2014 ("MAR") attached.
For further information, please contact:
Osvald Fossholm, Belships CFO
Phone +47 908 87 393 or e-mail osvald.fossholm@belships.no
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Danske Invest18.9.2026 13:53:34 CEST | Pressemeddelelse
Meddelelse vedrørende fusion af afdelinger under Investeringsforeningen Danske Invest
Nykredit Realkredit A/S18.9.2026 13:15:00 CEST | Pressemeddelelse
Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktioner
Nykredit Realkredit A/S18.9.2026 13:15:00 CEST | Pressemeddelelse
Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktioner
Investeringsforeningen PortfolioManager18.9.2026 13:00:00 CEST | Pressemeddelelse
Forslag om fusion af afdelinger under Investeringsforeningen PortfolioManager
F. Hoffmann-La Roche Ltd18.9.2026 12:45:00 CEST | Press release
CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom